Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LINCARE PHARMACY SERVICES INC.

NPI: 1134698418 · KANSAS CITY, MO 64116 · Community/Retail Pharmacy · NPI assigned 11/16/2018

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official BARNHARD, JEFFREY controls 20+ related entities in our dataset. Read more

$2.90M
Total Medicaid Paid
584,692
Total Claims
495,999
Beneficiaries
17
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBARNHARD, JEFFREY (CEO)
NPI Enumeration Date11/16/2018

Related Entities

Other providers sharing the same authorized official: BARNHARD, JEFFREY

ProviderCityStateTotal Paid
FOUNDERS HEALTHCARE, LLC PHOENIX AZ $66.75M
FOUNDERS HEALTHCARE, LLC TUCSON AZ $20.76M
FOUNDERS HEALTHCARE, LLC LAS VEGAS NV $18.86M
LINCARE INC. GREENWOOD IN $16.16M
LINCARE INC. FORT WAYNE IN $13.95M
LINCARE INC WESTERVILLE OH $12.98M
PATIENT SUPPORT SERVICES, INC TEXARKANA TX $10.33M
FOUNDERS HEALTHCARE, LLC GLENDALE AZ $8.92M
FOUNDERS HEALTHCARE LLC TEMPE AZ $7.47M
RCS MANAGEMENT CORP SURPRISE AZ $5.55M
LINCARE INC. SOUTH POINT OH $4.86M
LINCARE INC MORAINE OH $4.56M
LINCARE INC. ASHEVILLE NC $4.35M
LINCARE INC. CINCINNATI OH $4.34M
LINCARE INC TERRE HAUTE IN $4.31M
LINCARE INC BRIDGEPORT WV $3.97M
LINCARE INC. MADISON IN $3.66M
LINCARE INC. WINSTON-SALEM NC $3.55M
LINCARE INC. LARGO FL $3.08M
LINCARE INC. CONCORD CA $2.75M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 13,474 $77K
2019 95,660 $237K
2020 120,242 $447K
2021 141,646 $739K
2022 105,036 $695K
2023 76,083 $493K
2024 32,551 $216K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J7606 Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms 13,325 10,730 $716K
J7605 Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms 13,431 10,799 $565K
J7677 Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram 10,460 4,037 $506K
Q0513 Pharmacy dispensing fee for inhalation drug(s); per 30 days 130,534 111,409 $394K
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg 27,825 22,688 $228K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 100,759 83,995 $159K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 61,115 50,538 $127K
A7005 Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable 30,008 27,584 $62K
E0570 Nebulizer, with compressor 48,570 45,074 $46K
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 79,623 69,375 $39K
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 17,936 14,822 $24K
Q0514 Pharmacy dispensing fee for inhalation drug(s); per 90 days 1,248 1,152 $10K
G0333 Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary 2,807 2,398 $10K
E1390 Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate 120 101 $9K
A7015 Aerosol mask, used with dme nebulizer 35,512 30,926 $6K
A7013 Filter, disposable, used with aerosol compressor or ultrasonic generator 8,797 7,934 $1K
A7014 Filter, nondisposable, used with aerosol compressor or ultrasonic generator 2,622 2,437 $1K